Royal Caribbean Cruises sell BiotechBee
Start price
21.09.22
/
70%
€47.73
Target price
31.12.24
€39.00
Performance (%)
-2.79%
End price
02.01.23
€46.40
Summary
This prediction ended on 02.01.23 with a price of €46.40. With a performance of -2.79%, the SELL prediction for Royal Caribbean Cruises by BiotechBee was down slightly. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Royal Caribbean Cruises | 8.981% | 8.981% | 5.133% | 381.548% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
According to BiotechBee what are the pros and cons of Royal Caribbean Cruises for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Royal Caribbean Cruises diskutieren
Sell mit Kursziel 39,0